DOI:
10.1055/s-00034923
Adipositas - Ursachen, Folgeerkrankungen, Therapie
LinksClose Window
References
Willard FS, Douros JD, Gabe MB. et al.
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.
JCI Insight 2020;
5: e140532
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.